RxDoctor Payments DataLook up a doctor →

Eric Simoes

Pediatric Infectious Diseases · Aurora, CONPI 1902981632

Payments from drug & device makers

$12,178,618in general payments, 2019–2025

Across 580 payments — averaging $20,998 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$9.3M
  • Regeneron$1M
  • Merck$690K
  • AstraZeneca$460K
  • Astrazeneca UK Limited$319K
  • Sanofi Pasteur Inc.$145K
  • plus $221K from 9 others
$29,110in research payments, 2019–2025

Across 13 payments — averaging $2239.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$29K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer(2 entities)338$9,328,438
Regeneron15$1,015,844
Merck86$689,804
AstraZeneca26$459,772
Astrazeneca UK Limited14$318,934
Sanofi Pasteur Inc.67$145,234
GSK11$60,862
Sanofi US Services Inc.3$36,054
Janssen Research & Development, LLC2$34,641
AbbVie(2 entities)7$34,424
Modernatx, Inc.2$28,438
Genentech, Inc.2$24,353
Shionogi Inc1$1,300
Sobi, Inc5$425
Novavax Inc1$97

How this compares

$12,178,618 in reported general payments places this provider in the 95th percentile of 20 pediatric infectious diseases providers in Colorado.

See all pediatric infectious diseases providers in Colorado

Other pediatric infectious diseases in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →